Capitation Manag Rep. 2002 Jul;9(7):101-3, 97.
To counter the massive amount of drug company detailing and marketing that is partly responsible for driving up pharmaceutical costs, health plans and some independent practice associations are promoting the use of generics to physicians in their networks. While most physicians in capitated contracts don't directly benefit from the movement to encourage generics unless they have pharmacy risk, some health plans are paying physicians financial incentives to increase generic prescribing.
为应对制药公司大量的药品推广和营销活动(这些活动在一定程度上导致了药品成本的上升),健康计划机构和一些独立执业医师协会正在向其网络内的医生推广使用通用名药物。虽然参与按人头付费合同的大多数医生不会直接从鼓励使用通用名药物的行动中受益,除非他们承担药房风险,但一些健康计划机构正在向医生提供经济激励,以增加通用名药物的处方量。